Congenital Heart Disease in Children Clinical Trial
Official title:
Family Centred Early Intervention to Improve Motor Development of Infants With Severe Congenital Heart Disease
NCT number | NCT04666857 |
Other study ID # | EMI |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 31, 2021 |
Est. completion date | February 20, 2023 |
Verified date | September 2023 |
Source | University Children's Hospital, Zurich |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study the investigators aim to test the feasibility for therapists and acceptability to parents of an early motor intervention for infants with congenital heart disease (CHD) after open heart surgery. This intervention will be compared to the standard care of treatment that is recommended for infants with congenital heart disease at the University Children Hospital Zurich.
Status | Completed |
Enrollment | 10 |
Est. completion date | February 20, 2023 |
Est. primary completion date | December 19, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Months to 12 Months |
Eligibility | Inclusion Criteria: - Infants born with severe cyanotic and acyanotic congenital heart disease (e.g. tetralogy of Fallot, pulmonary atresia, transposition of the great arteries, atrial/ventricular septal defects, double outlet right ventricle, ...) who undergo open-heart surgery once before the first 3-6 months of their life - Parents able to comprehend the patient information linguistically and cognitively - Informed consent of parents as documented by signature Exclusion Criteria: - Infants with hypoplastic left heart syndrome as they need to undergo several open-heart surgeries within the first period of their life. - Infants with trisomy 21 and other syndromes like 22q11 microdeletion syndrome, CHARGE syndrome that are often associated with CHD. These infants often show additional cognitive impairments that might confound the effect of our intervention. |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Children's Hospital | Zürich |
Lead Sponsor | Collaborator |
---|---|
University Children's Hospital, Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Hammersmith Infant Neurological Examination | The Hammersmith Infant Neurological Examination assesses different aspects of neurological function.
the higher the scores the better, the range depends on the child's abilities metric: ordinal |
"3 up to 6 months of age" (baseline) and at "12 months of age" | |
Other | General Movements | The General Movement assessment is a video-based, non-invasive way to identify neurological deviations that may lead to neurodevelopmental disorders later in life.
The more variables the motor output of infants, the better infants' neuromotor development will be. metric: categorial |
"3 up to 6 months of age" (baseline) | |
Other | Infant Motor Profile | The Infant Motor Profile is a standardised and qualitative method to assess motor behaviour in infants, a 15 minutes, video-based assessment tool, consists of 5 domains: motor variation, adaptability, symmetry, fluency and performance.
The higher the score, the better - the range depends on the child's abilities and is age dependent metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention), at "12 months of age" | |
Other | Alberta Infant Motor Scale Change in being assessed at different time points at baseline, at the end of the intervention after three months and at follow up | The Alberta Infant Motor Scale is an observational measure of infants' gross motor development from birth until 18 months consisting of 58 items, measuring infants' performance; The higher the score, the better, the range depends on the child's abilities and is age dependent
metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Bayley Scale for Infant and Toddlers Development | Bayley Scale for Infant and Toddlers Development is an internationally used and validated battery to assesses key domains of cognition, language, socio-emotional, motor and adaptive behaviour by standardized observation and rating of the play behaviour of children the higher the scores the better, the range depends on the child's abilities and is age dependent metric: ordinal | "around 12 months of age" | |
Other | Parental Stress Index | The Parental Stress Index investigates parental stress of children with all different kind of diagnoses, consists of 5 subscales assessing areas where parental strain is high; the Parental Stress Index consists of 48 items the lower, the score the better
metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Brief Symptom Inventory 18 | The Brief Symptom Inventory 18 contains a three six-item scales somatization, depression, and anxiety as well as the Global Severity Index the lower, the score the better
metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Parental Overprotection Measure | The Parental Overprotection Measure assesses parenting behaviours that restrict a child's exposure to situations containing perceived threat or harm.
the higher the scores the more parents protect their children metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Family Empowerment Scale | The Family Empowerment Scale measures empowerment of families. It consists of three subscales, family, service system and community/political. We use the subscale family to gather relevant information as a result of an intervention.
the higher the scores the more the family feels empowered metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Quality of life form Short Form 36 | The Quality of life form Short Form 36 is a widely used questionnaire assessing self-reported health related quality of life the lower the score the better
metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Other | Pediatric Quality of Life Inventory | The Pediatric Quality of Life Inventory measures quality of life of infants aged 1- 24 months.
the higher the scores the more the quality of life is affected. metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age" | |
Primary | Dropout rate | The primary outcome will test the procedure for its acceptability, estimation the likely rates of recruitment and retention of subjects and the calculation of appropriate sample size. Further objectives are the usefulness of the outcome assessment measures. | "3 up to 6 months of age" (baseline) and at "12 months of age" |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05975658 -
WIReD: Wireless Interstage Remote Device Study
|
||
Completed |
NCT05546983 -
How to Report Postoperative Outcomes After a Paediatric Cardiac Surgery ?
|
||
Completed |
NCT03229538 -
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
|
Phase 3 | |
Completed |
NCT05579964 -
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
|
Phase 2/Phase 3 | |
Recruiting |
NCT05128084 -
Amotosalen and Platelet Transfusion in Pediatric Heart Surgery
|
||
Recruiting |
NCT04604418 -
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
|
||
Completed |
NCT05778240 -
Adherence to Palivizumab Prophylaxis
|
N/A | |
Terminated |
NCT03136900 -
Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants.
|
N/A | |
Recruiting |
NCT05910320 -
Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants
|
N/A | |
Not yet recruiting |
NCT05778175 -
Common Cases in Pediatric Intensive Care in Assuit University Cardiology Institute, a Clinical Audit
|
||
Completed |
NCT05284500 -
Predictive Pre and Peroperative Factors for MODS-2 in Pediatric Cardiac Surgery
|
||
Completed |
NCT04295239 -
Non-invasive Monitoring of Cerebral Self-regulation in Perioperative Neonatal Cardiac Surgery
|
N/A | |
Completed |
NCT05142046 -
Influence of Intraoperative Fluid Balance on the Incidence of Adverse Events in Pediatric Cardiac Surgery
|
||
Recruiting |
NCT04040452 -
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
|
Phase 4 | |
Not yet recruiting |
NCT06431269 -
Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
|
N/A | |
Recruiting |
NCT05268094 -
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
|
N/A | |
Recruiting |
NCT04315610 -
Personalized Mobile App for Parents of Infants With Cardiac Disease
|
N/A | |
Completed |
NCT04018079 -
Left Ventricular Dysfunction Post-surgical Patent Ductus Arteriosus Ligation in Children: Predictor Factors Analysis
|
||
Recruiting |
NCT05496803 -
Impact of Systematic Nursing Guidance on the Psychological Effects of Parents of Children With Cardiac Catheterization.
|
N/A | |
Recruiting |
NCT05826769 -
To Assess the Efficacy of Early Administration of Energy Enriched and Protein Enriched Formula in Post Cardiac Repair Infants: a Randomized Controlled Trial, Comparative Study
|
N/A |